Portfolio (Quarterly)
Guide ↗
Propel Bio Management, LLC
· CIK 0001969764| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PAGP | PLAINS GP HLDGS L P | Energy | 1,272,360.0 | $24.4M | 20.79% | NEW | — | $19.14 | +33.3% |
| 2 | — | ACHIEVE LIFE SCIENCES INC | — | 3,786,425.0 | $18.8M | 16.07% | NEW | — | $4.97 | — |
| 3 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 740,918.0 | $12.3M | 10.49% | NEW | — | $16.59 | -33.1% |
| 4 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 282,531.0 | $8.8M | 7.51% | NEW | — | $31.12 | -45.4% |
| 5 | MIST | MILESTONE PHARMACEUTICALS | Healthcare | 4,118,321.0 | $8.3M | 7.10% | NEW | — | $2.02 | -30.7% |
| 6 | KYTX | KYVERNA THERAPEUTICS INC | Healthcare | 666,666.0 | $6.3M | 5.35% | NEW | — | $9.40 | -8.4% |
| 7 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 861,778.0 | $5.9M | 5.08% | NEW | — | $6.90 | +77.2% |
| 8 | IVA | INVENTIVA SA - ADR | Healthcare | 1,000,000.0 | $4.7M | 3.97% | NEW | — | $4.65 | +11.0% |
| 9 | DCTH | DELCATH SYSTEMS INC | Healthcare | 438,509.0 | $4.4M | 3.78% | NEW | — | $10.10 | +7.2% |
| 10 | — | ABEONA THERAPEUTICS INC | — | 830,780.0 | $4.4M | 3.74% | NEW | — | $5.27 | — |
| 11 | CLDX | CELLDEX THERAPEUTICS INC | Healthcare | 154,300.0 | $4.2M | 3.58% | NEW | — | $27.16 | +13.6% |
| 12 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 82,822.0 | $3.5M | 2.99% | NEW | — | $42.28 | +55.1% |
| 13 | — | OCULIS HOLDING AG | — | 172,839.0 | $3.5M | 2.95% | NEW | — | $19.97 | — |
| 14 | — | SAB BIOTHERAPEUTICS INC | — | 652,881.0 | $2.4M | 2.08% | NEW | — | $3.74 | — |
| 15 | RGNX | REGENXBIO INC | Healthcare | 116,896.0 | $1.7M | 1.44% | NEW | — | $14.40 | -56.2% |
| 16 | LONA | ATHIRA PHARMA INC | Healthcare | 149,279.0 | $1.1M | 0.96% | NEW | — | $7.57 | +27.7% |
| 17 | LENZ | LENZ THERAPEUTICS INC | Healthcare | 59,085.0 | $945K | 0.81% | NEW | — | $16.00 | -51.6% |
| 18 | AARD | AARDVARK THERAPEUTICS INC | Healthcare | 46,408.0 | $609K | 0.52% | NEW | — | $13.12 | -68.0% |
| 19 | — | ZEVRA THERAPEUTICS INC | — | 63,683.0 | $571K | 0.49% | NEW | — | $8.96 | — |
| 20 | KLRS | KALARIS THERAPEUTICS INC | Healthcare | 42,053.0 | $355K | 0.30% | NEW | — | $8.44 | -38.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
72.2%
Energy
27.8%